chevron_leftBack
As of 24 April 2025, Sanara MedTech Inc. has a market cap of $269.02M USD, ranking #15563 globally and #2705 in the United States. It ranks #1531 in the Healthcare sector, and #130 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$269.02MUSD
Enterprise Value
$285.42MUSD
Revenue (TTM)
$86.67MUSD
EBITDA (TTM)
-$1.42MUSD
Net Income (TTM)
-$9.66MUSD
EBITDA Margin
-1.6%
Profit Margin
-11%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Ronald Nixon
open_in_new
Employees
141
Founded
1982
Website
sanaramedtech.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.3% | 5.4% | -10% | -20% | -10% | -8.1% |
Upcoming Earnings
Earnings Date
Mon, May 12
Earnings Time
bedtime
After Close
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SMTI
Sanara MedTech Inc
ISIN: US79957L1008
Shares Out.:
Shares Outstanding:
8.888M1
Shares Float:
2.982M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
30.22 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sanara MedTech Inc.
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKŌS Antimicrobial Wound Gel, and BIAKŌS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
